{"document_type": "article", "snippet": "The investment in the Pittsburgh-based start-up is part of K.K.R.\u2019s push into smaller growth-equity deals.", "type_of_material": "News", "web_url": "http://www.nytimes.com/2015/10/22/business/kohlberg-kravis-investing-50-million-in-cohera-medical.html", "subsection_name": null, "blog": [], "section_name": "Business Day", "source": "The New York Times", "pub_date": "2015-10-22T00:00:00Z", "word_count": "358", "slideshow_credits": null, "news_desk": "Business", "byline": {"original": "By MICHAEL. J. DE LA MERCED", "person": [{"role": "reported", "rank": 1, "organization": "", "firstname": "Michael"}]}, "abstract": null, "keywords": [{"value": "Venture Capital", "rank": "1", "name": "subject", "is_major": "N"}, {"value": "KKR & Co LP", "rank": "2", "name": "organizations", "is_major": "N"}], "print_page": null, "multimedia": [], "lead_paragraph": "The investment in the Pittsburgh-based start-up is part of K.K.R.\u2019s push into smaller growth-equity deals.", "headline": {"main": "Kohlberg Kravis Investing $50 Million in Cohera Medical"}, "_id": "56285af438f0d80f1ae08c2e"}